Economic consequences of preterm birth and low birthweight
- 1 April 2003
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 110 (s20) , 17-23
- https://doi.org/10.1046/j.1471-0528.2003.00013.x
Abstract
The high rates of mortality and morbidity arising from preterm birth and low birthweight impose an immense burden on the health, education and social services and on families. This was evaluated in several economic studies published in the 1970s and early 1980s, but an ability to intervene effectively to increase survival has transformed neonatal care over the past two decades. In addition, the relative prices of resource inputs are vastly different. This paper surveys the scientific literature on the economic consequences of preterm birth and low birthweight, including: (1) studies, which estimate the economic costs of the conditions and (2) economic evaluations of primary and secondary prevention and treatment strategies. This paper summarises the scope and scientific quality of the published evidence, identifies gaps in our knowledge and considers the future research agenda in this area.This publication has 38 references indexed in Scilit:
- Once- Versus Twice-daily Gentamicin Dosing in Neonates ≥34 Weeks' Gestation: Cost-effectiveness AnalysesPublished by American Academy of Pediatrics (AAP) ,1999
- Leave and Employment in Families of Preterm Low Birthweight InfantsImage: the Journal of Nursing Scholarship, 1996
- Cost of care for a geographically determined population of low birthweight infants to age 8-9 years. I. Children without disability.Archives of Disease in Childhood: Fetal & Neonatal, 1996
- The cost of neonatal care: Reviewing the evidenceInternational Journal of Public Health, 1995
- Theoretical Changes in Neonatal Hospitalisation Costs After the Introduction of Porcine-Derived Lung Surfactant (‘Curosurf’)PharmacoEconomics, 1995
- Synthetic surfactant for rescue treatment of respiratory distress syndrome in premature infants weighing from 700 to 1350 grams: Impact on hospital resource use and chargesThe Journal of Pediatrics, 1995
- Economic Outcomes of Colfosceril Palmitate Rescue Therapy in Infants Weighing 1250g or More with Respiratory Distress SyndromePharmacoEconomics, 1994
- Cost effects of surfactant therapy for neonatal respiratory distress syndromeThe Journal of Pediatrics, 1993
- A Randomized Clinical Trial of Early Hospital Discharge and Home Follow-up of Very-Low-Birth-Weight InfantsNew England Journal of Medicine, 1986
- Economic Evaluation of Neonatal Intensive Care of Very-Low-Birth-Weight InfantsNew England Journal of Medicine, 1983